Belvedere Trading’s NeueHealth NEUE Stock Holding History

Belvedere Trading’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-128	Closed	-$6.63K	–	1499
2022 Q4	$6.63K	Buy	+128	New	+$9.3K	﹤0.01%	951

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greycroft New York $146M AUM 1.94% 1-Year Est. Return

MCAV

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belvedere Trading's NEUE Position: Q1 2023 in Review

Belvedere Trading sold out of NeueHealth (NEUE) in Q1 2023, closing a stake of 128 shares — an estimated $6.67K sold.

Belvedere Trading first reported a position in NEUE in Q4 2022 and held it in 1 quarter. The position peaked at $6.67K in Q4 2022. 108 funds tracked by Wall St. Rank hold NEUE as of Q1 2023.

Belvedere Trading reported no remaining NeueHealth position as of Q1 2023 after selling out during the quarter.
Belvedere Trading sold 128 NeueHealth shares in Q1 2023, an estimated $6.67K.
Belvedere Trading first reported a position in NeueHealth in Q4 2022 and held it in 1 quarter.
Belvedere Trading's NeueHealth position peaked at $6.67K in Q4 2022.
108 funds tracked by Wall St. Rank held NeueHealth as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.